These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16733490)

  • 1. System for predicting outcome and for clinical evaluation in sepsis and septic shock: could scores and biochemical markers be of greater help in the future?
    Gentili A; Iannella E; Giuntoli L; Baroncini S
    Med Sci Monit; 2006 Jun; 12(6):LE11-2. PubMed ID: 16733490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of the severity of patient status in sepsis and septic shock].
    Rudnov VA; Beliaev SV; Nikolaev EK
    Anesteziol Reanimatol; 1995; (6):9-11. PubMed ID: 8713412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
    Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
    Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe sepsis and septic shock].
    Casanova MP; Peña JM; Rodríguez V; Ortega M; Celorrio LA
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):484-98. PubMed ID: 17993098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of hyperinflammation.
    Gerlach M; Gerlach H
    Minerva Anestesiol; 2002 Apr; 68(4):252-6. PubMed ID: 12024093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock.
    McLean AS; Huang SJ; Hyams S; Poh G; Nalos M; Pandit R; Balik M; Tang B; Seppelt I
    Crit Care Med; 2007 Apr; 35(4):1019-26. PubMed ID: 17334249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides: biomarkers not predictive in the intensive care unit.
    Ginsberg F; Topalian S
    Crit Care Med; 2007 Apr; 35(4):1194-5. PubMed ID: 17413786
    [No Abstract]   [Full Text] [Related]  

  • 8. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock.
    Kandil E; Burack J; Sawas A; Bibawy H; Schwartzman A; Zenilman ME; Bluth MH
    Arch Surg; 2008 Mar; 143(3):242-6; discussion 246. PubMed ID: 18347270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of circulating B-type natriuretic peptide in sepsis.
    Fujita T
    Arch Surg; 2008 Oct; 143(10):1021-2; author reply 1022-3. PubMed ID: 18936386
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation.
    Rivers EP; Ahrens T
    Crit Care Clin; 2008 Jul; 24(3 Suppl):S1-47. PubMed ID: 18634996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines of hemodynamic monitor and support in adult patients with severe sepsis and septic shock (draft)].
    Society of Critical Care Medicine, Chinese Medical Association
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):129-33. PubMed ID: 17376262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical disturbances in patients with Systemic Inflammatory Response Syndrome (SIRS) and sepsis. Part I. Biochemical disturbances in patients with sepsis].
    Paradowski M; Szablewski M; Piatas S; Majda J
    Przegl Epidemiol; 2005; 59(4):865-72. PubMed ID: 16729428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign.
    Townsend SR; Schorr C; Levy MM; Dellinger RP
    Clin Chest Med; 2008 Dec; 29(4):721-33, x. PubMed ID: 18954706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sepsis. Current aspects of its etiology, clinical aspects and prognosis in 220 patients].
    Warns CM; Fangmann B; Lobe H; Wagner J
    MMW Munch Med Wochenschr; 1982 May; 124(20):504-6. PubMed ID: 6808377
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure to implement evidence-based clinical guidelines for sepsis at the ED.
    De Miguel-Yanes JM; Andueza-Lillo JA; González-Ramallo VJ; Pastor L; Muñoz J
    Am J Emerg Med; 2006 Sep; 24(5):553-9. PubMed ID: 16938593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2008 international guidelines for management of severe sepsis and septic shock: merits and weaknesses.
    Antonelli M; Mercurio G
    Minerva Anestesiol; 2009; 75(1-2):27-9. PubMed ID: 19172144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent clinical trials for sepsis: analysis of the results and future perspectives].
    Wakabayashi G; Shimazu M; Tanabe M; Ueda M; Hoshino K; Morikawa Y; Kitajima M
    Nihon Geka Gakkai Zasshi; 1999 Oct; 100(10):674-8. PubMed ID: 10570778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systems approach to the early recognition and rapid administration of best practice therapy in sepsis and septic shock.
    Funk D; Sebat F; Kumar A
    Curr Opin Crit Care; 2009 Aug; 15(4):301-7. PubMed ID: 19561493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of PIRO as a new conceptual framework to understand sepsis.
    Opal SM
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S55-60. PubMed ID: 15857560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
    Mikkelsen ME; Miltiades AN; Gaieski DF; Goyal M; Fuchs BD; Shah CV; Bellamy SL; Christie JD
    Crit Care Med; 2009 May; 37(5):1670-7. PubMed ID: 19325467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.